Early Cancer Detection Purple DNA Organ Rejection Monitoring Liquid Biopsy

Brand Name:Orsin
Minimum Order Quantity:100
Payment Terms:L/C, D/A, D/P, T/T, Western Union
Place of Origin:China
Price:Negotiation
Material:Glass / pet
Contact Now

Add to Cart

Verified Supplier
Location: Shanghai Shanghai China
Address: Building A, No.599 Wanhua Road, Zhelin Town, Fengxian Area, Shanghai, China
Supplier`s last login times: within 1 hours
Product Details Company Profile
Product Details

  • Product Description: Cell-Free DNA (cfDNA) Collection and Preservation System by Orsin Medical Technology

    • 1. Product Description



    • Orsin Medical Technology revolutionizes liquid biopsy with our next-generation cfDNA Blood Collection Tube, engineered to deliver uncompromised sample quality for precision diagnostics and research.

      Why Choose Orsin’s cfDNA Tube?

    • Ultra-Stable Preservation – Proprietary formula inhibits hemolysis and nucleases, maintaining cfDNA integrity for extended periods.

    • Clinical-Grade Reliability – Validated for NIPT, oncology, and transplant monitoring, ensuring consistency across applications.

    • Seamless Workflow Integration – Compatible with automated extraction platforms and major downstream assays (qPCR, NGS, ddPCR).

    • Innovation in Every Tube:
      Our barrier-coated interior prevents gDNA contamination, while the vacuum-sealed design ensures leak-proof safety during transit.

      Ideal for:
      ✔ Early cancer detection
      ✔ Fetal genetic screening
      ✔ Minimal residual disease (MRD) monitoring
      ✔ Pathogen DNA analysis

    • Global Compliance – Manufactured under ISO 13485 standards for guaranteed performance.


  • 2. Specification



    ParameterDescription/Options
    Tube Cap ColorRed, Lavender (Purple), Green, Gray, Blue, Yellow, Black, etc.
    Additive TypeNone (Clot activator), EDTA, Heparin, Sodium Citrate, Sodium Fluoride, etc.
    Clinical UseSerum separation, Hematology, Coagulation, Chemistry, Glucose, Blood Bank, etc.
    Nominal Volume2ml, 3ml, 4ml, 5ml, 6ml, 7ml, 8ml, 10ml, etc.
    Draw Volume Range±10% of nominal volume (e.g., 4.5-5.5ml for 5ml tube)
    Tube Diameter13mm, 16mm (standard adult size)
    Tube Length75mm, 100mm, etc.
    MaterialPET plastic, Glass
    SterilizationGamma irradiation, EO Gas
    Expiry PeriodTypically 12-36 months (from date of manufacture)
    Hemolysis Rate≤0.1% (for most chemistry tubes)
    Clotting Time30 mins (for serum tubes with clot activator)
    Centrifuge Speed1300-2200g (tube material dependent)
    Safety FeaturesHemogard™ closure, BD-PTS, Needle protection system
    CertificationsISO 6710, CE Marked, FDA 510(k)

    Common Parameters by Tube Color (Example):


    Cap ColorAdditiveMixingInversion CountClinical Applications
    RedNone/Clot activator5-6Serum chemistry, Immunology
    LavenderK2/K3 EDTA8-10×8-10Hematology (CBC, Blood Smear)
    GreenLithium Heparin8-10×8-10Plasma chemistry, STAT tests
    GrayNaF/K Oxalate8-10×8-10Glucose tolerance, Alcohol tests
    BlueSodium Citrate3-4×3-4Coagulation tests (PT, APTT)

Clinical Performance Metrics

ApplicationSensitivitySpecificityPPVNPVLoD
NIPT T21>99%>99.9%>90%>99.9%2-4% FF
ctDNA MRD0.01% VAF95-99%80%98%0.1% MAF
dd-cfDNA85-92%78-85%75%90%0.5%

  • 3 . Application




  • 1.Precision Oncology Solutions

  • Unparalleled sensitivity for early detection

  • Serial monitoring capability for dynamic conditions

  • Comprehensive genomic coverage

  • Streamlined workflow integration

  • CLIA-certified analytical validity

  • Novel biomarker discovery pipelines

  • Clinical trial enrichment strategies

  • Pharmacodynamic endpoint development

  • Therapeutic target identification

  • 2.Research and Development Applications Biomedical Innovation

  • Cardiovascular event risk stratification

  • Neurodegenerative disease progression tracking

  • Autoimmune disorder monitoring

  • Metabolic disease assessment

  • 3.Chronic Disease Management

  • Rapid sepsis pathogen identification

  • Culture-resistant infection diagnosis

  • Antimicrobial resistance profiling

  • Viral load monitoring

  • 4.Cutting-Edge Diagnostic Applications Next-Generation Infection Detection

  • Real-time graft rejection monitoring via donor-derived DNA

  • Quantitative assessment of transplant engraftment success

  • Early detection of post-transplant complications

  • Personalized immunosuppression adjustment

  • 5.Transplant Medicine Advancements

  • Safe, accurate fetal chromosomal abnormality screening

  • Comprehensive genetic risk assessment from maternal circulation

  • Early prediction of pregnancy-related complications

  • Non-invasive fetal RhD status determination

  • 6.Advanced Prenatal Care

  • Early-stage tumor detection through ultra-sensitive ctDNA profiling

  • Dynamic monitoring of therapeutic efficacy and emerging resistance

  • Comprehensive metastatic assessment without invasive procedures

  • Personalized treatment selection through longitudinal mutation tracking

China Early Cancer Detection Purple DNA Organ Rejection Monitoring Liquid Biopsy supplier

Early Cancer Detection Purple DNA Organ Rejection Monitoring Liquid Biopsy

Inquiry Cart 0